Grace Therapeutics, Inc. (GRCE): Revenue

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Revenue is for the year ended 2022-03-31, while the company's latest annual report covers the year ended 2026-03-31. Its later filings do not report this line under the concept TickerFacts maps.

$100.00M
Year ended 2022-03-31
Period endedRevenueChange YoYSource filing
2022-03-31$100.00Mn/a2023-06-23, From 2021-04-01